Celera Genomics and Celera Diagnostics to Webcast Investor Meeting
Rockville, MD and Alameda, CA - December 06, 2001
Applera Corporation announced today that it will webcast a meeting with the investment community on Wednesday, December 12, 2001 that will discuss two of its businesses, Celera Genomics Group (NYSE: CRA) and Celera Diagnostics, a joint venture of Celera Genomics and the third Applera business, Applied Biosystems Group (NYSE:ABI). The webcast is scheduled to begin at 9 a.m. EST and to end at approximately 12:30 p.m. EST.
Tony L. White, Chief Executive Officer of Applera, Dr. J. Craig Venter, President and Chief Scientific Officer of Celera Genomics, and Kathy Ordoņez, President of Celera Diagnostics, will co-host the event and will be joined by other members of management from each of the two businesses and from Applera. Interested parties may access the webcast via the presentations sections of the investor relations sites at www.celera.com or www.appliedbiosystems.com. It is suggested that viewers access the webcast 15 minutes before the start of the broadcast.
Celera Genomics will discuss progress in the development of its therapeutic capabilities and programs, its online information business, and the integration of Axys Pharmaceuticals following the close of the acquisition. Celera Diagnostics will discuss its business and scientific plan.
About Celera Genomics, Celera Diagnostics, and Applera Corporation
Applera Corporation comprises two operating groups. The Applied Biosystems Group develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to market scientific discoveries, leading to the development of new pharmaceuticals, and to conduct standardized testing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.6 billion during fiscal 2001. The Celera Genomics Group, an integrated source of genomic and related medical information headquartered in Rockville, MD, is evolving to become a next generation therapeutic discovery business. Celera intends to leverage its industrialized approach to biology to develop platforms for enabling these new discoveries both for its own internal product development and for its customers, including collaboration partners and subscribers. Celera Diagnostics has been established as a joint venture between Applied Biosystems and Celera Genomics. This new venture is focused on discovery, development and commercialization of novel diagnostic tests. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available on the World Wide Web at www.applera.com, or by telephoning 800.762.6923.
Notice To Readers: Celera's press releases, presentations and printed remarks are included on this website for historical purposes only. The information contained in these documents should be considered accurate only as of the date of the relevant document. This information may change over time, and therefore visitors to this website should not assume that the information contained in these documents remains accurate at a later time. We do not have any current intention to update any of the information in these documents.